Merida Biosciences develops precision therapeutics targeting pathogenic antibodies to treat autoimmune and allergic diseases without broad immunosuppression.

Numab Therapeutics is a biotech company that develops multi-specific antibody-based immunotherapies for inflammation and cancer.

Ambrosia Biosciences develops orally delivered, small molecule-based therapies for obesity and metabolic disorders.

Alpha-9 Oncology Inc. develops targeted radiopharmaceuticals to improve cancer treatment.

Bambusa Therapeutics Inc. develops bispecific antibodies for treating immunological and inflammatory disorders.

Ambrosia Biosciences develops orally delivered, small molecule-based therapies for obesity and metabolic disorders.

Lassen Therapeutics is a clinical-stage biotech company developing novel treatments for fibro-inflammatory diseases and cancer, focusing on therapies targeting the IL-11 and IL-18 pathways.

Aro Biotherapeutics is a clinical stage biotech company specializing in the development of tissue-targeted genetic medicines, including a potential treatment for Pompe Disease and new therapies for autoimmune disorders, using their proprietary Centyrin-siRNA platform.

Forward Therapeutics is a company focused on advancing the development of next-generation small molecule immune therapies.

Nimbus Therapeutics is a clinical-stage company that uses computational chemistry and structure-based drug design to develop novel therapies for immunology, cancer, and metabolic diseases.